FDA Inspection 1260255 — Ondrej Mika, M.D.
The FDA completed an inspection of Ondrej Mika, M.D. on Jan 10, 2025 in Ceske Budejovice. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 10, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Ceske Budejovice (Czech Republic)
Additional Details
Clinical Investigator (CI)